Available Clinical Trials 

• A Randomized Study Evaluating Patients Discharged with Indwelling Chest Tube and Valve

  PI: K. Robert Shen, MD, Mayo Clinic Rochester

  Phase	Phase II
  Methodology	Randomized
  Overall Study Duration	5 years
  Subject Participation Duration	30 Days
  Objectives	Primary Objective To assess the efficacy of antibiotics and closer monitoring on decreasing empyema in patients discharging with a chest tube and valve in place as measured by documented empyema following discharge. Secondary Objective To assess the efficacy of antibiotics and closer monitoring on decreasing hospital readmissions while the chest tube and valve are in place as measured by readmission to the hospital following hospital discharge after the initial surgical intervention.
  Number of Subjects	560
  Diagnosis and Main Inclusion Criteria	Discharge from the hospital with an indwelling chest tube and valve in place
  Study Treatment	Oral antibiotics and close monitoring (defined as twice weekly telephone calls by a member of the care team)
  Reference Treatment	Standard of Care (defined as no calls from the care team but waiting for the subject to contact the care team when the air leak has stopped)
  Statistical Methodology	Comparison of the rate of empyema and readmission in the two arms of the study

   

• Protocal
• Consent 
• Schema 
  
• Contact for more Information